• Research Tree
  • Features
  • Pricing
  • Events
  • Reg.News
  • Short Interest
  • Explore Content
    • Explore

      • Providers
        • Providers

          • Free/Commissioned
          • High Net Worth Offering
          • Institutional Offering

          Free/Commissioned

          Research that is free to access for all investors. Companies commission these providers to write research about them.

          View Research

          What is our Main Bundle Offering?

          Brokers who write research on their corporate clients and make it available through our main bundle offering.

          View Research

          What is Institutional?

          Research that is paid for directly by asset managers. Only accessible to institutional investors permissioned for access.

          View Research
      • Regions
        • Regions

          • UK
          • Rest of EMEA
          • N America
          • APAC
          • LatAm
      • Exchanges
        • Exchanges

          • Aquis Apex
          • Australian Securities Exchange
          • Canadian Securities Exchange
          • Euronext Paris
          • London Stock Exchange (domestic)
          • SIX Swiss Exchange
      • Sectors
        • Sector Coverage

          • Building & Construction
          • Discretionary Personal Goods
          • Discretionary Retail
          • Energy
          • Health
          • Investment Trusts
          • Media
          • Resources
          • Technology
      • Small / Large Cap
        • Small / Large Cap

          • UK100
          • UK250
          • UK Smallcap
          • UK Other Main Markets
          • Other
  • Login
  • Sign Up
LIVE

Event in Progress:

Join Here ×

working
  • 10 Apr 2024

BQE: Q4 Financials Preview


BQE Water Inc (BQE:TSX) | 0 0 0.0%


  • Atrium Research
    • Nicholas Cortellucci, CFA

    • 3 pages


 

What you need to know: • BQE will be reporting Q4 & 2023 financial results in ~2 weeks, we are expecting proportional revenue of $4.2M, gross margin of 45%, and adj. EBITDA of $0.6M (14% margin). • Metals prices have been rising steadily over the last month with copper up 9%. BQE’s China JV has leverage to the copper price as it sells recovered metals. • BQE remains cheap at 10.0x/8.6x 2024E/2025E EBITDA. BQE Water (BQE:TSXV, BTQNF:OTC) will be reporting Q4 and 2023 financial results around April 25th. We are expecting another strong quarter from BQE, albeit Q4 being a seasonally weak quarter. An overview of our estimates can be found below. BQE stock is up 47% since our initiation report last month (read here), yet we are still highly bullish in our thesis and will reassess our target price on the back of the financial results. We are maintaining our BUY rating and $55.00/share target price on BQE Water. Q4 & 2023 Financials Preview For Q4, we are expecting: • Proportional revenue of $4.2M (-2% YoY) comprised of reported revenue at $2.8M and share of JV revenue at $1.4M • Gross margin of 45% compared to 41% in Q4/22 (note that this is reported as operating margin before depreciation) • Adjusted EBITDA of $0.6M (14% margin) compared to ($0.1M) in Q4/22 • Net income of $0.4M or $0.29/share compared to ($0.2M) or ($0.19/share) in Q4/22 For 2023, we are expecting: • Proportional revenue of $21.5M (+14% YoY) comprised of reported revenue at $15.9M and share of JV revenue at $5.6M • Gross margin of 48% compared to 42% in 2022 • Adjusted EBITDA of $4.7M (22% margin) compared to $3.1M (16% margin) in 2022 • Net income of $2.8M or $2.22/share vs. $1.2M or $0.93/share in 2022

Sign up for free to access

Get access to the latest equity research in real-time from 12 commissioned providers.

Get access to the latest equity research in real-time from 12 commissioned providers.


Get Started
Already a member? Log in here
See all the research we have on this company.

BQE: Q4 Financials Preview


BQE Water Inc (BQE:TSX) | 0 0 0.0%


  • Published: 10 Apr 2024
  • Author: Nicholas Cortellucci, CFA
  • Pages: 3
  • Atrium Research


What you need to know: • BQE will be reporting Q4 & 2023 financial results in ~2 weeks, we are expecting proportional revenue of $4.2M, gross margin of 45%, and adj. EBITDA of $0.6M (14% margin). • Metals prices have been rising steadily over the last month with copper up 9%. BQE’s China JV has leverage to the copper price as it sells recovered metals. • BQE remains cheap at 10.0x/8.6x 2024E/2025E EBITDA. BQE Water (BQE:TSXV, BTQNF:OTC) will be reporting Q4 and 2023 financial results around April 25th. We are expecting another strong quarter from BQE, albeit Q4 being a seasonally weak quarter. An overview of our estimates can be found below. BQE stock is up 47% since our initiation report last month (read here), yet we are still highly bullish in our thesis and will reassess our target price on the back of the financial results. We are maintaining our BUY rating and $55.00/share target price on BQE Water. Q4 & 2023 Financials Preview For Q4, we are expecting: • Proportional revenue of $4.2M (-2% YoY) comprised of reported revenue at $2.8M and share of JV revenue at $1.4M • Gross margin of 45% compared to 41% in Q4/22 (note that this is reported as operating margin before depreciation) • Adjusted EBITDA of $0.6M (14% margin) compared to ($0.1M) in Q4/22 • Net income of $0.4M or $0.29/share compared to ($0.2M) or ($0.19/share) in Q4/22 For 2023, we are expecting: • Proportional revenue of $21.5M (+14% YoY) comprised of reported revenue at $15.9M and share of JV revenue at $5.6M • Gross margin of 48% compared to 42% in 2022 • Adjusted EBITDA of $4.7M (22% margin) compared to $3.1M (16% margin) in 2022 • Net income of $2.8M or $2.22/share vs. $1.2M or $0.93/share in 2022

More Content

More Content

BQE: Expanded Service Offering to Support Growth Strategy

Companies: BQE Water Inc

Atrium Research

BQE: Profitable & Growing Micro-Cap in the Water Treatment Industry

Companies: BQE Water Inc

Atrium Research

BQE: Contract Extended for Emergency Water Treatment

Companies: BQE Water Inc

Atrium Research

BQE: Excellent Q4 Financials; Increasing Target Price

Companies: BQE Water Inc

Atrium Research

Q2/25 Recap: All Our Research in One Place!

Companies: NIM CUU VAPE SCZ DRX AUAU ARG OMG BQE CUU DNG EDG KRI KNR KRI MOO NIM RIO SBIO LVG TM SCZ CAPT GIGA MSA APM VAPE FISH

Atrium Research
Research Tree
Useful Links
  • Features
  • Pricing
  • RNS/Newswires Feeds
  • Providers Hub
  • Company Hub
  • Stock Pick League
  • Chrome Extension
  • iOS and Android Apps
  • LLM Feed
Account
  • Login
  • Join Now
  • Contact
  • Follow us on Linkedin
  • Follow us on X

© Research Tree 2025

  • Apple Store
  • Play Store
  • Terms of Service
  • Privacy Policy and Statement on Cookies

Research Tree will never share your details with third parties for marketing purposes. Research Tree distributes research documents that have been produced and approved by Financial Conduct Authority (FCA) Authorised & Regulated firms as well as relevant content from non-authorised sources, who are not regulated but the information is in the public domain. For the avoidance of doubt Research Tree is not giving advice, nor has Research Tree validated any of the information.

Research Tree is an Appointed Representative of Sturgeon Ventures which is Authorised and Regulated by the Financial Conduct Authority.

Top
  • Home
  • Features
  • Pricing
  • Event Hub
  • Reg.News
  • Short Interest Tracker
  • Explore Content
    • Regions
      • UK
      • Rest of EMEA
      • N America
      • APAC
      • LatAm
    • Exchanges
      • Aquis Apex
      • Australian Securities Exchange
      • Canadian Securities Exchange
      • Euronext Paris
      • London Stock Exchange (domestic)
      • SIX Swiss Exchange
    • Sectors
      • Automobile Industry
      • Banks
      • Building & Construction
      • Chemicals
      • Discretionary Personal Goods
      • Discretionary Retail
      • Energy
      • ETFs
      • Financial Services
      • Food & Drink
      • Food Production
      • Health
      • Household Goods & DIY
      • Industrial Equipment, Goods & Services
      • Insurance & Reinsurance
      • Investment Trusts
      • Leisure, Tourism & Travel
      • Media
      • Open-ended Funds
      • Other
      • Real Estate
      • Resources
      • Staple Retail
      • Technology
      • Telecoms
      • Trusts, ETFs & Funds
      • Utilities
    • Small / Large Cap
      • UK100
      • UK250
      • UK Smallcap
      • UK Other Main Markets
      • Other
    • Private/EIS
      • EIS Single Company
      • EIS/SEIS Funds
      • IHT Products
      • SEIS Single Company
      • VCT Funds
  • Providers
    • Free/Commissioned
      • Actinver
      • Actio Advisors
      • Asset TV
      • Astris Advisory
      • Atrium Research
      • Baden Hill
      • BlytheRay
      • BNP Paribas Exane - Sponsored Research
      • Bondcritic
      • Brand Communications
      • Brokerlink
      • BRR Media
      • Calvine Partners
      • Capital Access Group
      • Capital Link
      • Capital Markets Brokers
      • Cavendish
      • Checkpoint Partners
      • Clear Capital Markets
      • Couloir Capital
      • Doceo
      • Edison
      • Engage Investor
      • Equity Development
      • eResearch
      • First Equity
      • Five Minute Pitch TV
      • focusIR
      • Fundamental Research Corp
      • Galliano’s Latin Notes
      • GBC AG
      • goetzpartners securities Limited
      • Golden Section Capital
      • GreenSome Finance
      • GSBR Research
      • H2 Radnor
      • Hardman & Co
      • Holland Advisors
      • Hypothesis Research
      • InterAxS Global
      • Kepler | Trust Intelligence
      • London Stock Exchange
      • Longspur Clean Energy
      • Mello Events
      • Messari Research
      • MUFG Corporate Markets IR
      • Nippon Investment Bespoke Research UK
      • NuWays
      • OAK Securities
      • Oberon Capital
      • Optimo Capital
      • Panmure Liberum
      • Paul Scott
      • Peel Hunt
      • PIWORLD / Progressive
      • Proactive
      • Progressive Equity Research
      • Quantum Research Group
      • QuotedData
      • Research Dynamics
      • Research Tree
      • Resolve Research
      • SEAL Advisors Ltd
      • ShareSoc
      • Shore Capital
      • Sidoti & Company
      • Small Cap Consumer Research LLC
      • StockBox
      • Tennyson Securities
      • The AIC
      • The Business Magazine Group
      • The Edge Group
      • The Life Sciences Division
      • Trinity Delta
      • Turner Pope Investments
      • UK Investor Group
      • ValueTrack
      • Vox Markets
      • VRS International S.A. - Valuation & Research Specialists (VRS)
      • VSA Capital
      • Winterflood Securities
      • World Platinum Investment Council
      • Yaru Investments
      • Yellowstone Advisory
      • Zacks Small Cap Research
      • Zeus Capital
    • High Net Worth Offering
      • Fox-Davies Capital
      • ABG Sundal Collier
      • ACF Equity Research
      • Acquisdata
      • Align Research
      • Allenby Capital
      • AlphaValue
      • Alternative Resource Capital
      • Arctic Securities
      • Arden Partners
      • Auctus Advisors
      • Baptista Research
      • BNP Paribas Exane - Sponsored Research
      • Canaccord Genuity
      • Cavendish
      • Couloir Capital
      • Degroof Petercam
      • Dowgate Capital
      • First Berlin
      • First Equity
      • First Sentinel
      • Greenwood Capital Partners
      • Hannam & Partners
      • Hybridan
      • Kemeny Capital
      • Longspur Clean Energy
      • Louis Capital
      • Magnitogorsk Iron and steel works
      • Medley Global Advisors
      • Northland Capital Partners
      • OAK Securities
      • Oberon Capital
      • Panmure Liberum
      • QuotedData Professional
      • Shard Capital
      • ShareSoc
      • Shore Capital
      • Singer Capital Markets
      • SP Angel
      • Stanford Capital Partners
      • Stifel FirstEnergy
      • Stockdale Securities
      • Tamesis Partners
      • Tennyson Securities
      • The Life Sciences Division
      • Turner Pope Investments
      • VSA Capital
      • Whitman Howard
      • Yellowstone Advisory
      • Zeus Capital
    • Institutional Offering
      • Fox-Davies Capital
      • ABG Sundal Collier
      • ACF Equity Research
      • Allenby Capital
      • Alternative Resource Capital
      • Arctic Securities
      • Arden Partners
      • Auctus Advisors
      • BNP Paribas Exane
      • Bondcritic
      • Canaccord Genuity
      • Capital Access Group
      • Capital Link
      • Cavendish
      • Couloir Capital
      • Degroof Petercam
      • Dowgate Capital
      • Edison
      • First Berlin
      • First Equity
      • First Sentinel
      • Five Minute Pitch TV
      • Fundamental Research Corp
      • Galliano’s Latin Notes
      • GBC AG
      • Golden Section Capital
      • Goodbody
      • Greenwood Capital Partners
      • Hannam & Partners
      • Holland Advisors
      • Hybridan
      • InterAxS Global
      • Investec Bank
      • Kepler | Trust Intelligence
      • Numis
      • NuWays
      • OAK Securities
      • Oberon Capital
      • Panmure Liberum
      • Peel Hunt
      • QuotedData
      • QuotedData Professional
      • Research Dynamics
      • Research Tree
      • Shard Capital
      • Shore Capital
      • Sidoti & Company
      • Singer Capital Markets
      • Small Cap Consumer Research LLC
      • SP Angel
      • Stanford Capital Partners
      • Stifel
      • StockBox
      • Tamesis Partners
      • Tennyson Securities
      • The AIC
      • The Business Magazine Group
      • The Life Sciences Division
      • ValueTrack
      • Velocity Trade
      • VSA Capital
      • Winterflood Securities
      • World Platinum Investment Council
      • Zacks Small Cap Research
      • Zeus Capital
  • Contact
  • Sign Up
  • Sign In